Cargando…
Effects of NRAS Mutations on Leukemogenesis and Targeting of Children With Acute Lymphoblastic Leukemia
Through the advancements in recent decades, childhood acute lymphoblastic leukemia (ALL) is gradually becoming a highly curable disease. However, the truth is there remaining relapse in ∼15% of ALL cases with dismal outcomes. RAS mutations, in particular NRAS mutations, were predominant mutations af...
Autores principales: | Qian, Jiabi, Li, Zifeng, Pei, Kunlin, Li, Ziping, Li, Chunjie, Yan, Muxia, Qian, Maoxiang, Song, Yuanbin, Zhang, Hui, He, Yingyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861515/ https://www.ncbi.nlm.nih.gov/pubmed/35211470 http://dx.doi.org/10.3389/fcell.2022.712484 |
Ejemplares similares
-
Association Between NR3C1 Mutations and Glucocorticoid Resistance in Children With Acute Lymphoblastic Leukemia
por: Liu, Haiyan, et al.
Publicado: (2021) -
The functional role of inherited CDKN2A variants in childhood acute lymphoblastic leukemia
por: Li, Chunjie, et al.
Publicado: (2021) -
Inherited GATA3 variant associated with positive minimal residual disease in childhood B‐cell acute lymphoblastic leukemia via asparaginase resistance
por: Li, Chunjie, et al.
Publicado: (2021) -
Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia
por: Zheng, Qingqing, et al.
Publicado: (2020) -
The progress in the relationship between trace elements and acute lymphoblastic leukemia
por: Wang, Jing, et al.
Publicado: (2023)